Companies › InSilico Medicine Hong Kong
6 active drug programs in 7 registered trials: 4 Phase 1, 2 Phase 2, 1 Phase 3; Oncology, Immunology, Respiratory, Cardiovascular; next expected readout Nov 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Rentosertib (INS018_055) ALK5 inhibitor | – | Phase 3 | Idiopathic Pulmonary Fibrosis; Idiopathic Pulmonary Fibrosis (IPF) | Oct 2029 |
| ISM5411 (Garutadustat) PHF8 inhibitor | PHF8 | Phase 2 | Ulcerative Colitis | Aug 2027 |
| ISM8207 | – | Phase 1 | Advanced Solid Tumors | Nov 2026 |
| ISM8969 | – | Phase 1 | Healthy Subjects (HS) | Jan 2027 |
| ISM6331 | – | Phase 1 | Malignant Mesothelioma | Aug 2027 |
| ISM3412 | – | Phase 1 | Locally Advanced/Metastatic Solid Tumors | Mar 2028 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05975983 | Rentosertib (INS018_055) | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) | Respiratory | Feb 2026 |
| NCT06445517 | ISM8207 | Phase 1 | Advanced Solid Tumors | Oncology | Nov 2026 |
| NCT07581431 | ISM8969 | Phase 1 | Healthy Subjects (HS) | Cardiovascular | Jan 2027 |
| NCT07265570 | ISM5411 (Garutadustat) | Phase 2 | Ulcerative Colitis | Immunology | Aug 2027 |
| NCT06566079 | ISM6331 | Phase 1 | Malignant Mesothelioma | Oncology | Aug 2027 |
| NCT06414460 | ISM3412 | Phase 1 | Locally Advanced/Metastatic Solid Tumors | Oncology | Mar 2028 |
| NCT07687459 | Rentosertib (INS018_055) | Phase 3 | Idiopathic Pulmonary Fibrosis | Respiratory | Oct 2029 |
–
Jemincare Jacobio Pharmaceuticals DualityBio Deciphera Pharmaceuticals Chengdu New Radiomedicine Technology
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.